Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis  by Winau, Florian et al.
Immunity 24, 105–117, January 2006 ª2006 Elsevier Inc. DOI 10.1016/j.immuni.2005.12.001Apoptotic Vesicles Crossprime CD8 T Cells
and Protect against TuberculosisFlorian Winau,1,* Stephan Weber,1 Subash Sad,4
Juana de Diego,2 Silvia Locatelli Hoops,5
Bernadette Breiden,5 Konrad Sandhoff,5
Volker Brinkmann,3 Stefan H.E. Kaufmann,1,6
and Ulrich E. Schaible1,6
1Department of Immunology
2Department of Cellular Microbiology
3Central Core Facility Microscopy
Max-Planck-Institute for Infection Biology
Schumannstrasse 21-22
10117 Berlin
Germany
4 Institute for Biological Science
National Research Council of Canada
100 Sussex Drive
Ottawa, Ontario K1A 0R6
Canada
5Kekule´ Institute of Organic Chemistry
and Biochemistry
Gerhard-Domagk-Strasse 1
53121 Bonn
Germany
Summary
CD8 T lymphocytes are important effectors in protec-
tive immunity against Mycobacterium tuberculosis.
We recently characterized the detour pathway of CD8
T cell activation in tuberculosis mediated by apoptotic
vesicles from infected cells that transport mycobacte-
rial antigens to dendritic cells (DCs). Here we demon-
strate that apoptotic vesicles from mycobacteria-
infected macrophages stimulate CD8 T cells in vivo.
Homing of DCs to draining lymph nodes was critically
required for effective crosspriming. Subsequent fate
of vesicle-associated antigens in recipient DCs was
characterized by endosomalmechanismspredominat-
ing over proteasomal processing. In addition, vesicle
processing depended on the presence of saposins to
disintegrate apoptotic membranes. Apoptotic vesicles
displayed potent adjuvant activity by stimulating
through Toll-like receptors (TLR). Ultimately, vaccina-
tion with vesicles from infected cells induced protec-
tion againstM. tuberculosis infection. Taken together,
we propose the detour pathway to represent a genuine
immunological mechanismmediating crosspriming of
CD8Tcells in vivo andprotection against tuberculosis.
Introduction
Tuberculosis is the most prevalent bacterial infectious
disease worldwide (Kaufmann and McMichael, 2005).
Immunity against its etiologic agent, Mycobacterium tu-
berculosis, mainly involves CD4 T cells. Yet, CD8 T cells
play a vital role in protection against tuberculosis, since
*Correspondence: winau@mpiib-berlin.mpg.de
6 These authors contributed equally to this work.lack of CD8 T cells causes higher susceptibility to myco-
bacterial challenge (Kaufmann, 2001). M. tuberculosis
primarily infects macrophages of the lung. After infec-
tion, mycobacteria reside in early phagosomes and es-
cape the immune system by inhibiting phagosome mat-
uration and fusion with lysosomes (Russell, 2003).
Moreover, mycobacterial antigens are segregated in
phagosomes and do not traverse into the cytoplasm
(Schaible et al., 2003). Since CD8 T cells recognize anti-
gens originating from the cytosol to be processed along
the MHC-I antigen-presentation pathway, the critical
question has been how CD8 T cells encounter their re-
spective mycobacterial epitopes. Previous work de-
scribed the detour pathway of CD8 T cell activation in tu-
berculosis to overcome this obstacle (Schaible et al.,
2003). Thus, mycobacteria induce apoptosis of infected
macrophages, which subsequently release apoptotic
vesicles containing mycobacterial antigens. These
vesicles are engulfed by DCs, which process the anti-
genic cargo for subsequent presentation to CD8 T cells.
Therefore, the detour pathway represents an exclusive
mechanism of CD8 T cell activation by phagosome-
enclosed antigens (Winau et al., 2004a).
Initially, the relation between apoptosis and T cell
activation has been described in viral infection where
dying infected cells promote priming of CD8 T cells by
cocultured DCs (Albert et al., 1998). This mechanism in-
volving transfer from a donor cell harboring the antigen
to a recipient cell, eventually mediating antigen presen-
tation, is referred to as crosspresentation or crossprim-
ing related to T cell activation (Bevan, 1976). The detour
pathway comprehends classical crosspriming, the latter
being demonstrated for multiple tumor and infection
models (Ackerman and Cresswell, 2004). Several patho-
gens including salmonellae and shigellae induce apo-
ptosis of infected host cells (Sansonetti et al., 2000;
Weinrauch and Zychlinsky, 1999). However, apoptotic
vesicles as crosspriming agents have not been identi-
fied in these model systems. Different modes can ex-
plain the mechanism of crosspriming (Winau et al.,
2005). Recent data demonstrated that the phagosome
of antigen-presenting cells (APCs) is equipped with the
complete molecular apparatus required for MHC-I-
restricted antigen presentation including transporters
associated with antigen presentation (TAP), the peptide
loading complex, and adjacent proteasomes (Guermon-
prez et al., 2003; Houde et al., 2003). This suggests that
the phagosome constitutes an autonomous organelle
facilitating direct crosspresentation by the primary cell.
However, novel studies could not confirm these findings
(Touret et al., 2005; Groothuis and Neefjes, 2005).
Because the detour pathway was discovered in the
human in vitro system, crosspriming of CD8 T cells could
merely represent bystander activation by neighboring
DCs taking up apoptotic vesicles in terms of an inflam-
matory process. To investigate whether the apoptotic
vesicle path reflects a veritable immunological mecha-
nism spanning uptake of vesicles by DCs in peripheral
tissue, subsequent migration to draining lymph nodes,
and priming of T cells in lymphatic tissue, we set up an
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combinant Mycobacterium bovis BCG expressing the
defined surrogate antigen ovalbumin (BCG-OVA) for in-
fection of macrophages. Since inhibition of intrinsic infec-
tion-induced apoptosis of the host is not feasible, we re-
garded extrinsic control of vesicle formation upon cell
death by infected APCs as the most reliable approach.
We immunized mice with apoptotic vesicles from in-
fected macrophages and adoptively transferred TCR-
transgenic CD8 T cells specific for OVA to recipients,
subsequently analyzing in vivo activation of CD8 T cells.
Results
Mycobacteria Induce Apoptotic Vesicles
After infection of macrophages, mycobacteria elicit reg-
ulated cell death of host cells (Schaible et al., 2003). In
order to visualize apoptosis, we performed Annexin V
staining of murine macrophages after infection with re-
combinant BCG-OVA. Annexin V binds to phosphatidyl-
serine characteristically exposed on the outer leaflet of
apoptotic membranes. Figure 1A reveals red fluores-
cence of Annexin V staining of BCG-OVA-infected
macrophages, indicating apoptosis in contrast to nonin-
fected cells. As control of apoptotic cell death, stauro-
sporine was included, which activates caspase-3 and
the subsequent apoptotic cascade.
Scanning electron microscopy (SEM) revealed vesicle
formation of macrophages undergoing infection-in-
duced apoptosis (Figure 1B). Remarkably, dying macro-
phages exhibited a string phenotype with apoptotic
vesicles budding from cellular cords (Figure 1B, middle).
Differential ultracentrifugation of apoptotic macrophage
supernatants resulted in a homogenous vesicle prepa-
ration as indicated by SEM (Figure 1B, bottom).
To examine whether the surrogate antigen of re-
combinant BCG is present in apoptotic vesicles, we
conducted immunoblots of vesicle protein with a mono-
clonal antibody against ovalbumin. Bands of w12 kDa
corresponded to the OVA fragment (amino acids 230–
359) expressed by BCG and were absent in apoptotic
vesicles from noninfected macrophages (Figure 1C).
Taken together, the generation of apoptotic vesicles
containing surrogate antigen from BCG-OVA-infected
macrophages proved to be fully functional.
Crosspriming of CD8 T Cells by Apoptotic Vesicles
In order to investigate whether apoptotic vesicles acti-
vate naive CD8 T cells in vivo, we immunized wild-type
mice subcutaneously with vesicle preparations from in-
fected or naive macrophages. In parallel, we isolated
CD8 T cells from TCR-transgenic animals (OT-1) specific
for the OVA determinant SIINFEKL. Subsequently, we la-
beled the OT-1 cells with carboxyfluorescein diacetate
succinimidylester (CFSE) before adoptive transfer to re-
cipient immunized mice. This dye is equally partitioned
upon cell division, allowing the generation of prolifera-
tion profiles. Three days after transfer, lymphocytes
were prepared from draining lymph nodes and stained
for CD8. Flow cytometric analysis revealed substantial
activation of transferred CD8 T cells stimulated with
vesicles from infected cells indicated by CFSE dilution
(Figure 2A, top right). In contrast, CD8 T cells of recipient
animals immunized with apoptotic vesicles from nonin-fected macrophages or vesicles from cells infected
with wild-type BCG (not expressing OVA) did not prolif-
erate (Figure 2A, top left, and data not shown). More-
over, intracellular cytokine staining demonstrated that
CD8 T cells produced increasing amounts of inter-
feron-g (IFN-g) upon division compared to OT-1 cells
after stimulation with vesicles from noninfected cells
(Figure 2A, bottom).
Next, we examined the impact of antigen-presenting
molecules associated with apoptotic vesicles with re-
gard to T cell activation. To this end, we generated
vesicles lacking MHC-I molecules by infecting macro-
phages deficient in b2 microglobulin (b2m). Immuniza-
tion with apoptotic vesicles from infected b2m-KO mac-
rophages induced proper CD8 T cell activation in vivo in
contrast to stimulation with vesicles derived from unin-
fected cells (Figure 2B).
The use of apoptotic vesicles generated from infected
wild-type cells for stimulation of transferred OT-1 cells in
b2m-deficient animals elicited a moderate CD8 T cell re-
sponse (Figure 2C, top). However, the extent of CD8 T
cell proliferation observed indicated potential transmis-
sion of MHC-I molecules from apoptotic vesicles to b2m-
deficient recipient cells lacking MHC-I proteins. To verify
this notion, we conducted an in vitro assay employing
b2m-deficient DCs as APCs and CD8
+-sorted OT-1 lym-
phocytes as responder cells. When DCs lacking MHC-I
were pulsed with apoptotic vesicles from BCG-infected
macrophages, no antigen-specific activation of CD8 T
cells was detectable. In marked contrast, addition of
vesicles from BCG-OVA-infected cells induced robust
T cell proliferation as determined by 3H-thymidine incor-
poration. Stimulation of OT-1 cells with vesicles from
BCG-OVA-infected macrophages in the absence of
b2m-deficient DCs failed to induce CD8 T cell activation
(Figure 2C, bottom). Thus, a direct impact of apoptotic
vesicles on OT-1 cells or OT-1 cell-mediated antigen
presentation can be excluded.
Further, we analyzed the priming capacity of apopto-
tic vesicles with regard to other T cell populations. We
performed adoptive transfer of TCR-transgenic CD4
T cells specific for OVA peptides in the context of
MHC-II and immunized recipient mice with vesicles
from infected or noninfected macrophages. Figure 2D
demonstrates that apoptotic vesicles from infected cells
potently activate CD4 T cells.
In conclusion, apoptotic vesicles efficiently cross-
prime CD8 T cells in vivo. In addition to antigen delivery,
vesicles are able to transmit antigen-presenting mole-
cules to recipient APCs. Vesicle-induced T cell activa-
tion includes priming of CD4 T cells.
The Detour Pathway Requires Homing of DCs
Because we observed CD8 T cell activation in draining
lymph nodes after subcutaneous immunization with apo-
ptotic vesicles, we aimed at elucidating the mode of
transport of vesicles between peripheral and lymphatic
tissue. Taking into account the two possibilities of vesi-
cle transport either directly by the lymph or by a vehicle
cell, we labeled apoptotic vesicles with a fluorochrome
prior to subcutaneous injection in order to determine
their destination. One day after application of labeled
vesicles, we excised draining lymph nodes for cryosec-
tion. After staining the tissue with antibodies against the
Crosspriming of T Cells by Apoptotic Vesicles
107Figure 1. Mycobacteria Induce Apoptotic Vesicles
(A) Recombinant BCG elicits apoptosis of infected macrophages. Bone marrow-derived macrophages were infected with BCG-OVA at an moi of
10:1 for 4 hr. One day later, cells were fixed and stained with Annexin V (red fluorescence). As controls, macrophages were left uninfected or were
treated with staurosporine. Left panels represent images by fluorescence microscopy and right panels are phase contrast.
(B) Dying macrophages exhibit a string phenotype. Macrophages were infected with BCG, fixed, and analyzed by scanning electron microscopy.
The lower panel shows a preparation of apoptotic vesicles after differential ultracentrifugation of cell-culture supernatants from infected macro-
phages. Scale bars equal 5 mm in the upper panel, 500 nm in the lower panels.
(C) Vesicles from BCG-OVA-infected cells contain surrogate antigen. Apoptotic vesicle proteins were separated by SDS-PAGE, blotted to nitro-
cellulose, and stained with an ovalbumin antibody. A band of w12 kDa corresponding to the OVA fragment is demonstrated for apoptotic
vesicles from infected macrophages in contrast to naive vesicles. Coomassie-stained bands represent the corresponding protein gel.DC marker CD11c and the macrophage-specific surface
protein F4/80, we examined the lymph node sections un-
der a confocal microscope. Figure 3A shows the mutu-
ally exclusive staining of DCs (CD11c+) and macro-
phages (F4/80+) in lymph node sections (top left). Linesof red fluorescent vesicles were detected in draining
lymph nodes after subcutaneous injection (Figure 3A,
bottom middle). The location of labeled apoptotic
vesicles superimposed on the staining for DCs (Figure
3A, bottom left). The overlay of DCs and vesicles largely
Immunity
108Figure 2. Crosspriming of T Cells by Apopto-
tic Vesicles
(A) CD8 T cell activation by apoptotic vesicles
in vivo. Wild-type mice were immunized with
apoptotic vesicles from infected (Infected)
or noninfected (Naive) macrophages and re-
ceived in parallel CFSE-labeled OT-1 cells
by adoptive transfer. Three days after stimu-
lation, cells were isolated from draining
lymph nodes and stained for CD8 and intra-
cellular IFN-g. Left dot plots represent stimu-
lation with naive vesicles (Naive), right dot
plots show activation by vesicles from in-
fected cells (Infected). Lower panels are
gated on CD8+ T cells. wt / wt = vesicles
from wild-type donor macrophages injected
into wild-type recipient mice. Mean of 45%
(65%; Infected) or 4% (62%; Naive) dividing
cells of total CFSE+ CD8 T cells from three in-
dependent experiments with similar results.
(B) MHC-I molecules on apoptotic vesicles
are not required for CD8 T cell activation. Af-
ter a similar experimental set-up as described
in (A), we immunized mice with apoptotic
vesicles from b2m-deficient macrophages.
Left dot plot represents stimulation with naive
(Naive), right dot plot with vesicles from in-
fected (Infected) cells. b2m
2/2 / wt =
vesicles from b2m
2/2 donor macrophages in-
jected into wild-type recipient mice. Mean of
54% (69%; Infected) or 8% (64%; Naive) di-
viding cells of total CFSE+ CD8 T cells from
three independent experiments with similar
results.
(C) Apoptotic vesicles transmit MHC-I mole-
cules to recipient APCs. By a similar ap-
proach as in (A) and (B), we immunized b2m-
deficient mice with apoptotic vesicles from
wild-type macrophages. Left dot plot: stimu-
lation with naive vesicles (Naive); right dot
plot: activation with vesicles from infected
cells (Infected). wt / b2m
2/2 = vesicles
from wild-type donor macrophages injected
into b2m
2/2 recipient mice. The lower graph
shows an in vitro experiment with b2m-defi-
cient DCs as APCs in coculture with OT-1
cells. Irradiated DCs were left untreated
(Neg. control) or were pulsed with vesicles
from BCG- or BCG-OVA-infected macro-
phages. Additionally, OT-1 cells only were
stimulated with vesicles from BCG-OVA-in-
fected cells. Two days after incubation, anti-
gen-specific proliferation was determined
by 3H-thymidine incorporation as depicted
by counts per minute (cpm).
(D) Activation of CD4 T cells by apoptotic
vesicles. Three days after immunization of
mice with vesicles and adoptive transfer of
CFSE-labeled OT-2 cells, lymph node cells
were isolated and stained for CD4. Left dot
plot represents stimulation with naive
vesicles (Naive), right dot plot activation with vesicles from infected cells (Infected). wt/ wt = vesicles from wild-type donor macrophages in-
jected into wild-type recipient mice. Mean of 50% (610%; Infected) or 5% (64%; Naive) dividing cells of total CFSE+ CD4 T cells from three in-
dependent experiments with similar results.demonstrated colocalization, indicating that apoptotic
vesicles were taken up by DCs (Figure 3A, bottom right).
Remarkably, resident lymph node cells such as macro-
phages did not contain labeled material (Figure 3A, top
right), suggesting that DCs engulfed vesicles in the pe-
riphery and subsequently migrated to the draining lymph
node.In addition to these morphological data, we per-
formed functional experiments on homing of DCs. We
took advantage of mice deficient for chemokine recep-
tor 7 (CCR7), which is expressed by naive and memory
T cells as well as mature DCs as prerequisite for homing
to lymphatic tissue (Martin-Fontecha et al., 2003). We
immunized CCR7-deficient animals with apoptotic
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(A) Apoptotic vesicles are allocated to DCs. The upper left confocal picture shows an overlay of a lymph node section stained for the DC marker
CD11c (green) and the macrophage-specific molecule F4/80 (blue). The upper right picture represents an overlay demonstrating the presence of
red fluorescent material in the draining lymph node after subcutaneous injection of labeled apoptotic vesicles and staining for the macrophage
marker F4/80 (blue). The lower left confocal picture shows a lymph node section stained for CD11c (green). The lower middle image demonstrates
red fluorescent apoptotic vesicles in the same draining lymph node section. Both images are merged to overlay, depicted in the lower right panel.
(B) Homing of DCs is required for crosspriming of CD8 T cells. Wild-type (wt) and CCR7-deficient (CCR72/2) mice were subcutaneously immu-
nized with apoptotic vesicles from mycobacteria-infected macrophages and received CFSE-labeled OT-1 cells by adoptive transfer (top). As
controls, CCR7-deficient animals (CCR72/2) received CFSE-labeled OT-1 cells and wild-type DCs (+ WT-DC) unpulsed or pulsed with SIINFEKL
peptide (+ WT-DC/Peptide; bottom). Three days after stimulation, cells from draining lymph nodes were isolated and stained for CD8.vesicles from BCG-OVA-infected macrophages and
adoptively transferred CFSE-labeled OT-1 cells in paral-
lel. Three days after transfer, cells from lymph nodeswere isolated and stained for CD8. Analysis by flow cy-
tometry revealed lack of CD8 T cell activation in CCR7-
knockout mice in contrast to the proliferative response
Immunity
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Proteasomal Processing of Apoptotic
Vesicles
Irradiated DCs were pulsed with vesicles
from BCG-OVA-infected macrophages
(Vesicles) or left untreated (No antigen) before
coculture with CD8+-sorted OT-1 cells in vi-
tro. Moreover, APCs were incubated with ba-
filomycin (Bafi) or MG 132 (MG) in low or high
concentrations before addition of T cells. OT-
1 cells only (OT-1 alone) incubated with apo-
ptotic vesicles from BCG-OVA-infected mac-
rophages were also included. In addition,
DCs were pulsed with low or high peptide
concentrations or soluble ovalbumin (OVA; 5
mg/ml), or were infected with L.m.-OVA at
a moi of 5 for 30 min before incubation with in-
hibitors and CD8 or CD4 T cells (OT-2). Two
days after stimulation, antigen-specific CD8
or CD4 T cell proliferation was measured by
3H-thymidine incorporation as depicted by
counts per minute (cpm). Data are represen-
tative for two independent experiments with
similar results. *p < 0.05; **p < 0.01; ***p <
0.001 as analyzed by Student’s t test.in wild-type animals (Figure 3B, top). To exclude an in-
trinsic deficiency of CCR72/2 mice to prime wild-type
CD8 T cells, we transferred wild-type DCs unpulsed or
pulsed with SIINFEKL peptide in parallel to OT-1 cells
to CCR72/2 recipients. Three days after adoptive trans-
fer, flow cytometric analysis revealed proper antigen-
specific CD8 T cell activation (Figure 3B, bottom). Taken
together, our functional experiments in the CCR7-defi-
cient system verify the morphological data and indicate
that homing of DCs is critically required for crosspriming
of CD8 T cells by apoptotic vesicles.
Processing of Apoptotic Vesicles in DCs
Since DCs emerged as central to crosspriming of CD8 T
cells by apoptotic vesicles, we further focused on differ-
ential processing of vesicles in APCs. An in vitro T cell
assay was set up with bone marrow-derived DCs as
APCs in coculture with CD8+-purified OT-1 cells as re-
sponder T cells. After pulsing DCs with apoptotic
vesicles derived from BCG-OVA-infected macrophages,
CD8 T cells responded with antigen-specific prolifera-
tion as measured by 3H-thymidine incorporation of di-
viding OT-1 cells. Treatment of DCs with bafilomycin
prior to incubation with vesicles and addition of T cells
abrogated the CD8 T cell response in a dose-dependentmanner (Figure 4, top). Bafilomycin blocks the endoso-
mal H+-ATPase, which facilitates acidification of late en-
dosomes and lysosomes. Thus, inhibition of OT-1 cell
stimulation by bafilomycin demonstrated the impor-
tance of endosomal processing of apoptotic vesicles
for CD8 T cell activation. Preincubation of APCs with
the proteasome inhibitor MG 132 had only a minor im-
pact on T cell activation (Figure 4, top). In order to ex-
clude effects on antigen presentation of cells present
among CD8 T cells, we pulsed OT-1 cells with vesicles
from infected macrophages that failed to induce T cell
activation. To exclude toxic effects of the chemical in-
hibitors used, we pulsed DCs with low (0.1 mg/ml) or
high (1 mg/ml) concentrations of SIINFEKL peptide prior
to incubation with bafilomycin or MG 132 and subse-
quent addition of CD8 T cells. Since impairment of the
T cell response to peptide presentation was not ob-
served, any toxic effect of the inhibitors can be excluded
(Figure 4, top). The use of ovalbumin (5 mg/ml) in the
same experimental set-up revealed abrogation of the T
cell response in the presence of MG 132, indicating the
importance of proteasomes in crosspriming of CD8 T
cells by soluble protein (Figure 4, bottom). To assess
the efficacy of proteasome and lysosomal acidification
block, we infected DCs with recombinant Listeria
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5 in the presence of the inhibitors. Due to the action of
listeriolysin, listeria are able to induce membrane pores
escaping the phagosome to reach the cytosol rapidly af-
ter infection. This enabled us to study the impact of MG
132 on processing of cytosolic protein. Figure 4 (bottom)
demonstrates the complete block of antigen recognition
due to inhibition of the proteasome. Of note, neutraliza-
tion of the endosomal compartment also reduced T cell
activation since listeriolysin deploys optimal activity in
an acidic milieu. Finally, to investigate the impact of ba-
filomycin and MG 132 on MHC-II restricted antigen pre-
sentation, we pulsed DCs with ovalbumin (5 mg/ml) prior
to incubation with the inhibitors and addition of ovalbu-
min-specific CD4 T cells (OT-2). Inhibition of endosomal
acidification efficiently abrogated antigen recognition
by CD4 T cells, whereas proteasome block had no effect
(Figure 4, bottom). Taken together, endosomal predomi-
nated over proteasomal mechanisms concerning pro-
cessing of antigen contained in apoptotic vesicles for
subsequent CD8 T cell induction.
Since we identified the lysosomal compartment as vi-
tal for antigen editing of apoptotic vesicles, we ques-
tioned whether other lysosomal helper molecules were
required for vesicle processing. Previous studies de-
scribed saposins as lipid transfer proteins located in
the lysosome that interact with intralysosomal vesicles
(Schuette et al., 2001; Kolter and Sandhoff, 2005).
Thereby saposins destabilize membrane structures
and expose their constituents for further processing
(Vaccaro et al., 1995). Apoptotic and intralysosomal
vesicles exhibit some analogy in structure. Moreover,
saposins possess high affinity for phosphatidylserine
classically exposed on the surface of apoptotic mem-
branes. Thus, we proposed a role of saposins in disinte-
gration of apoptotic vesicles and performed experi-
ments with DCs from mice lacking prosaposin, the
precursor protein of saposins A-D, for CD8 T cell activa-
tion. When APCs generated from prosaposin-deficient
animals were pulsed with different concentrations of
vesicles from BCG-OVA-infected macrophages, the
CD8 T cell response was significantly reduced com-
pared to stimulation with heterozygous or wild-type
control DCs (Figure 5). After reconstitution of prosapo-
sin-deficient APCs by addition of recombinant prosapo-
sin to cell culture, the T cell response was largely re-
stored. Loading of prosaposin-knockout APCs with
different concentrations of SIINFEKL peptide induced
a vigorous CD8 T cell response, which showed an other-
wise physiological MHC-I-restricted antigen presenta-
tion capacity (Figure 5). Moreover, addition of soluble
ovalbumin (5 mg/ml) revealed an equal magnitude of T
cell activation by prosaposin-deficient APCs compared
to heterozygous or wild-type DCs (Figure 5). Thus, a gen-
eralized defect in antigen processing due to absence of
prosaposin can be excluded. Additionally, we previously
demonstrated that the lysosomal compartment of pro-
saposin-deficient cells is anatomically intact and that
apart from a-glucosidase function, they exhibit normal
activity of lysosomal enzymes such as b-hexosamini-
dase and b-galactosidase (Winau et al., 2004b). Taken
together, lack of prosaposin impaired CD8 T cell activa-
tion, demonstrating a role of saposins in processing of
apoptotic vesicles.Apoptotic Vesicles Are Adjuvants
Productive T cell responses depend on sufficient anti-
gen presentation by potent APCs like macrophages
and DCs (Mellman and Steinman, 2001; Shortman and
Liu, 2002). Successful T cell priming is facilitated by ac-
tivation of APCs. Pathogens possess conserved mole-
cules such as lipopolysaccharide (LPS) or bacterial lipo-
protein (BLP), which stimulate APCs through Toll-like
receptors (TLR) (Medzhitov, 2001). We determined
whether apoptotic vesicles from BCG-infected macro-
phages are equipped with mycobacterial ligands that
stimulate APCs through TLRs. To this end, we used
the stably transfected 293 HEK cell line expressing
TLR-2, which was transiently cotransfected with an
NF-kB-regulated luciferase reporter plasmid. After
TLR-2 ligation, recruitment of the adaptor molecule my-
eloid differentiation factor 88 (MyD88) leads to NF-kB ac-
tivation and subsequent expression of luciferase. One
day after cotransfection, cells were incubated with in-
creasing amounts of apoptotic vesicles from infected
or noninfected macrophages. After 6 hr, cells were lysed
and tested for NF-kB-dependent luciferase activity.
Apoptotic vesicles from mycobacteria-infected macro-
phages elicited NF-kB activation in a dose-dependent
manner in contrast to vesicles from uninfected cells (Fig-
ure 6A). In order to extend our insights from a reporter
cell system to more natural conditions, we stimulated
primary APCs deficient for TLR-2, TLR-4, or MyD88
with apoptotic vesicles. DCs or macrophages from the
respective knockout animals were pulsed either with
vesicles from infected or noninfected cells or BCG. Sub-
sequently, cell cultures were analyzed for IL-12 or TNF-
a secretion. Vesicles from infected cells induced signifi-
cant amounts of IL-12 in wild-type DCs, which was
largely reduced in TLR-2-, TLR-4-, and MyD88-KO
DCs, whereas stimulation with BCG led to IL-12/IL-23
p40 secretion by wild-type as well as TLR-4-KO DCs
(Figure 6B). Vesicles also failed to induce TLR-2-defi-
cient macrophages to secrete TNF-a in contrast to
wild-type or TLR-4-KO macrophages (Figure 6C). Con-
sistent with this finding, cells lacking the adaptor mole-
cule MyD88 were not activated by vesicles from infected
macrophages. In conclusion, apoptotic vesicles from
mycobacteria-infected cells exhibit strong adjuvanticity
by activation of APCs through TLR-2 engagement.
In order to characterize the mycobacterial content of
apoptotic vesicles, we performed immunoblots with
protein from vesicles derived from mycobacteria-in-
fected compared to noninfected cells. Figure 6D dem-
onstrates abundant bands of mycobacterial proteins
present in vesicles detected by a polyclonal anti-BCG
serum. One of these proteins corresponded to a w31
kDa band reflecting Ag85, a protective antigen shared
by M. tuberculosis and BCG (Huygen et al., 1996), as re-
vealed by a specific antibody (Figure 6D). Additionally,
molecules were detected by immunoblot that represent
both antigens and adjuvants. Thus, mycobacterial 19
kDa lipoprotein, which binds to TLR-2 and serves as T
cell antigen (Lopez et al., 2003), was present in apoptotic
vesicles from infected macrophages (Figure 6D). Taken
together, mycobacterial proteins such as the 19 kDa
lipoprotein are constituents of the vesicular protein
content and confer strong adjuvanticity to apoptotic
vesicles.
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112Figure 5. Saposins Play a Fundamental Role
in Disintegration of Apoptotic Vesicles
Prosaposin-deficient (pSAP2/2) DCs were
pulsed with different concentrations of apo-
ptotic vesicles from BCG-OVA-infected mac-
rophages and incubated with OT-1 cells com-
pared to DCs from heterozygous (pSAP+/2)
mice. Additionally, DCs were reconstituted
with prosaposin 24 hr before the assay. Dif-
ferent concentrations of SIINFEKL were
used to pulse DCs as antigen presentation
controls. Soluble ovalbumin (5 mg/ml) was
added to control normal function of antigen
processing. Two days after stimulation, anti-
gen-specific CD8 T cell proliferation was
measured by 3H-thymidine incorporation as
depicted by counts per minute (cpm). Graphs
are representative for three independent
experiments with similar results. *p < 0.05;
**p < 0.01; ***p < 0.001 as analyzed by Stu-
dent’s t test.Vaccination with Apoptotic Vesicles Protects
against Tuberculosis
Because apoptotic vesicles from mycobacteria-infected
cells carry antigen, antigen-presenting molecules, and
adjuvants, they are able to efficiently activate CD4 as
well as CD8 T cells. Therefore, we examined the protec-
tive efficacy of the vesicle-based vaccine against infec-
tion with M. tuberculosis. We vaccinated C57BL/6 mice
subcutaneously twice at an interval of 10 days with apo-
ptotic vesicles from BCG-infected or noninfected mac-
rophages. As positive controls, we included animals im-
munized with BCG, the current vaccine against
tuberculosis. 10 days after the last immunization, we
challenged mice with a low inoculum M. tuberculosis
by aerosol infection. On day 20 and 50 postinfection,
we collected lungs, livers, and spleens from experimen-
tal animals and plated homogenized organs in serial di-
lutions on 7H11 agar. Three weeks later, M. tuberculosis
colonies were counted and CFU per ml organ were de-
termined. Vesicles from noninfected cells failed to pro-
tect against M. tuberculosis infection comparable to
the nonvaccinated group (Figure 7). In marked contrast,
vaccination with apoptotic vesicles from mycobacteria-infected macrophages induced protection against aero-
sol challenge as determined in lung and spleen both at
day 20 and day 50 in the order of BCG-induced protec-
tion (Figures 7A–7C). Differences in CFU between
groups vaccinated with vesicles from infected macro-
phages or BCG and nonvaccinated groups or those vac-
cinated with vesicles from noninfected macrophages
were statistically significant. Due to spontaneous reduc-
tion of bacterial burden of nonvaccinated mice, lung
CFU at day 50 were higher in nonvaccinated compared
to vaccinated animals while not statistically significant
(Figure 7B). However, at the same time point after infec-
tion, protection induced by the vesicle-based vaccine
was significant in spleen compared to the nonvacci-
nated group (Figure 7C). To conclude, vaccination with
apoptotic vesicles protects against tuberculosis.
Discussion
The aim of this study was to investigate whether the de-
tour pathway of CD8 T cell activation is operative in vivo.
Since previous work focused on analysis of human
in vitro systems (Schaible et al., 2003), the question
Crosspriming of T Cells by Apoptotic Vesicles
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(A) TLR-2 binds apoptotic vesicles. 293 HEK cells constitutively expressing TLR-2 were transiently cotransfected with an NF-kB-regulated lucif-
erase reporter plasmid. One day after transfection, cells were incubated with vesicles from mycobacteria-infected (Vesicles-BCG) or noninfected
(Vesicles-naive) macrophages. 6 hr after stimulation, cells were lysed and luciferase activity was determined. Ordinate represents induction of
NF-kB activation indicated by relative luciferase units (RLU).
(B and C) Apoptotic vesicles activate primary APCs through TLR-2. Bone marrow-derived DCs (B) and macrophages (C) generated from wild-
type C57BL/6, TLR-2-, TLR-4-, or MyD88-knockout animals were incubated with either vesicles from infected or noninfected cells or BCG. Pro-
tein concentrations of all three preparations were adjusted to 5 mg/ml. After stimulation for 1 (macrophages) or 2 (DCs) days, supernatants were
harvested for detection of IL-12/IL-23 p40 (B) or TNF-a (C) by ELISA. Ordinate indicates cytokine concentration in pg/ml. Data are representative
for three independent experiments with similar results. *p < 0.03; **p < 0.004; ***p < 0.0004 as analyzed by Student’s t test.
(D) Apoptotic vesicles contain mycobacterial antigens and adjuvants. Apoptotic vesicle protein from infected macrophages or naive cells was
separated by SDS-PAGE, blotted to nitrocellulose, and stained with anti-BCG serum, Ag85, or 19 kDa lipoprotein antibodies. The size of the
bands detected can be deduced from the corresponding protein standard. Coomassie-stained bands represent the corresponding protein gel.remained whether the apoptotic vesicle path represents
a unique immunological mechanism instead of mere by-
stander activation characteristic for inflammatory pro-cesses. Thus, we established an antigen-specific model
with apoptotic vesicles from BCG-OVA-infected macro-
phages for immunization of mice receiving OVA-specific
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volves induction of apoptosis by M. tuberculosis upon
infection of macrophages, which subsequently release
apoptotic vesicles containing mycobacterial antigens.
Figure 7. Vaccination with Apoptotic Vesicles Protects against Tu-
berculosis
Mice were vaccinated subcutaneously with apoptotic vesicles from
infected or noninfected macrophages. As controls, animals were im-
munized with the standard vaccine BCG or were left untreated. 10
days after the last immunization, mice were challenged with M. tu-
berculosis aerosol infection (138 CFU per mouse). 20 and 50 days af-
ter challenge, lungs and spleens were collected, homogenized, and
plated on agar in serial dilution. Three weeks later, M. tuberculosis
colonies were counted.
(A) Ordinate represents M. tuberculosisCFU/ml in lungs at day 20 for
the depicted experimental groups.
(B) Ordinate represents CFU/ml in lungs determined 50 days postin-
fection.
(C) Ordinate represents the CFU/ml in spleens at day 50 after infec-
tion. Colony counts in spleens at day 20 postinfection were low and
heterogenous but revealed a similar trend (data not shown).
*p < 0.05; **p < 0.01; ***p < 0.001; ns, no significance, as analyzed by
Tukey’s multiple-comparison test.DCs engulf these vesicles for further processing and ac-
tivation of CD8 T cells by antigens otherwise segregated
in phagosomes (Winau et al., 2004a). Our studies of in-
fection-induced apoptosis by scanning electron micros-
copy revealed a string phenotype of mycobacteria-
infected macrophages showing vesicles blebbing from
cellular cords.
Subcutaneous immunization with apoptotic vesicles
from mycobacteria-infected macrophages induced
CD8 T cell activation in draining lymph nodes. Thus,
crosspriming by apoptotic vesicles occurs in vivo. De-
spite conflicting data in some viral and tumor systems
(Ochsenbein et al., 2001; Freigang et al., 2003; Zinkerna-
gel, 2002), the importance of crosspriming has been es-
tablished in numerous models with tumors, infections,
and defined antigens like OVA (Thomas et al., 2004;
Storni and Bachmann, 2004; Ackerman and Cresswell,
2004). Crosspriming initiated by pathogen-induced apo-
ptosis has been described for infection with viruses and
bacteria (Albert et al., 1998; Yrlid and Wick, 2000). Sev-
eral pathogens induce apoptosis in host cells (Wein-
rauch and Zychlinsky, 1999), suggesting that the detour
pathway represents a general mechanism for cross-
priming of CD8 T cells in infectious disease. In Listeria
monocytogenes infection, a crucial role of neutrophils
in crosspriming of listeria-specific CD8 T cells has
been shown (Tvinnereim et al., 2004). Moreover, neutro-
phils are primary target cells of listeriae and other path-
ogenic invaders and undergo apoptosis upon infection.
Thus, it is likely that the detour pathway is valid for a mul-
titude of crosspriming conditions. However, apoptotic
vesicles have not been identified in these models. Differ-
ent vesicle structures have been described as efficient
agents in T cell crosspriming, termed exosomes (Thery
et al., 2002). These vesicles represent secreted lyso-
somes, constitutively released by cells independently
from cell death. Exosomal transfer of antigens as part
of the detour pathway has been excluded, since inhibi-
tion of apoptosis in donor macrophages totally abro-
gates activation of CD8 T cells (Schaible et al., 2003).
CD8 T cells activated by apoptotic vesicles from my-
cobacteria-infected cells produced IFN-g, which is cen-
tral to control of tuberculosis (Kaufmann, 2001). Notably,
IFN-g stimulates uninfected macrophages to produce
reactive nitrogen intermediates in order to effectively
kill intracellularM. tuberculosis. Moreover, we examined
the impact of antigen-presenting molecules associated
with apoptotic vesicles on T cell activation. When mice
were immunized with vesicles from b2m-deficient mac-
rophages devoid of MHC-I surface expression, proper
CD8 T cell activation was observed as indicated by anti-
gen-specific proliferation. Thus, the presence of MHC-I
molecules on apoptotic vesicles is not required for
crosspriming. Vesicles from wild-type macrophages in-
duced definite, but weak, CD8 T cell proliferation in b2m-
KO-recipient mice, suggesting that transfer of MHC-I
molecules from apoptotic vesicles to recipient APCs
occurred in vivo. However, the weak T cell response
could be due to quantitatively minor transfer of MHC-I
proteins. In order to verify MHC-I transmittance, we
pulsed DCs from b2m-KO mice with apoptotic vesicles
for subsequent T cell stimulation in vitro. Indeed, apo-
ptotic vesicles reconstituted b2m-deficient APCs for
MHC-I-restricted antigen presentation. Moreover, we
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by apoptotic vesicles. MHC-II-restricted CD4 T cells,
which are activated by exogenous antigens through
the endosomal pathway, play an important role in pro-
tective immunity against tuberculosis. Crosspriming is
also crucial for CD4 T cell activation in tuberculosis,
since infected macrophages are hampered in MHC-II
presentation due to mycobacterial interference with
IFN-g signaling (Wojciechowski et al., 1999).
Recent data suggest that DCs are responsible for
crosspriming of CD8 T cells in vivo (den Haan et al.,
2000; den Haan and Bevan, 2002). Since we observed
T cell activation in draining lymph nodes, we experimen-
tally determined how the antigen was transported from
the periphery to the lymphatic tissue. After subcutane-
ous injection of fluorescent vesicles, subsequent stain-
ing of DCs and macrophages in draining lymph node
sections demonstrated exclusive allocation of vesicles
to DCs. Uptake of particulate antigen by DCs in periph-
eral tissue for subsequent transport to draining lymph
nodes is in accordance with studies showing that solu-
ble rather than particulate antigens can be directly
drained by the lymph for cell-independent transport to
secondary lymphoid organs (Itano and Jenkins, 2003).
Moreover, immunization of CCR7-deficient animals
with apoptotic vesicles failed to induce CD8 T cell acti-
vation. CCR7 is expressed on naive and memory T cells
as well as activated DCs and is critically required for
homing to lymphatic tissue (Martin-Fontecha et al.,
2003). Main ligands for CCR7 are CCL21 and CCL19,
which are produced by endothelial cells of lymphatic
vessels and high endothelial venules as well as stromal
cells and mature DCs of lymphatic T cell zones. Our re-
sults demonstrate that homing of DCs is a prerequisite
for crosspriming of CD8 T cells by apoptotic vesicles.
Processing of antigen contained in apoptotic vesicles
in recipient DCs mainly involved endosomal mecha-
nisms rather than proteasomal cleavage as shown by
chemical inhibition of either pathways. This contrasts re-
cent data that found dependency on TAP and protea-
somes of crosspriming by cell-associated antigens
(Fonteneau et al., 2003). Two options of antigen pro-
cessing independently from proteasomes can be envis-
aged. First, OVA could be present in apoptotic vesicles
in an already processed form directly available for
MHC-I binding. We consider this option unlikely be-
cause we identified complete OVA molecules by immu-
noblot analysis of apoptotic vesicles. More importantly,
recent studies revealed the nature of crosspriming anti-
gens defined by maturity of proteins (Shen and Rock,
2004). Unstable peptides with a shorter half-life than ma-
ture proteins were insufficient for crosspresentation
(Wolkers et al., 2004; Norbury et al., 2004). Second,
OVA could be processed in recipient APCs independent
from proteasomal cleavage. Indeed, recent experiments
identified an exclusive endosomal mechanism of anti-
gen editing for crosspresentation mediated by cathep-
sin S not involving TAP and proteasomes (Shen et al.,
2004; Rock and Shen, 2005).
Apoptotic vesicles represent membrane structures,
which supposedly are disintegrated as prerequisite for
further processing of their antigenic content. Saposins
A-D are lipid transfer proteins ubiquitiously present in
lysosomes generated by cleavage from the commonprecursor prosaposin (Schuette et al., 2001). Saposins
exhibit a dual function in binding to proteins as well as
lipids, and they are essential cofactors of enzymes in-
volved in lipid degradation (O’Brien and Kishimoto,
1991; Kolter and Sandhoff, 2005). Moreover, saposins
bind to phospholipid membranes, thereby destabilizing
the integrity of intralysosomal vesicles, which renders
vesicular constituents accessible for further processing
(Vaccaro et al., 1995). Previous work described that sap-
osins are capable of extracting antigens from mem-
branes (Winau et al., 2004b). Due to the structural anal-
ogy between intralysosomal and apoptotic vesicles and
the high affinity of saposins to phosphatidylserine ex-
posed on apoptotic membranes (Henson et al., 2001),
we analyzed prosaposin-deficient APCs for antigen pre-
sentation of apoptotic vesicles. Indeed, prosaposin-
deficient DCs failed to activate CD8 T cells by vesicles
from mycobacteria-infected macrophages compared
to wild-type APCs. Reconstitution of saposin-deficient
APCs by exogenous prosaposin restored their antigen-
presenting capacity. Thus, saposins perform vital func-
tions in disintegration of apoptotic vesicles for cross-
priming of CD8 T cells.
Activation and maturation of APCs is an essential pre-
condition for efficient T cell activation. In infectious dis-
ease, TLRs on DCs and macrophages mediate APC
activation through binding of pathogen components
(Medzhitov et al., 1997). TLRs are pattern recognition re-
ceptors (PRR) that sense the presence of pathogens in
the macroorganism by binding of conserved pathogenic
structures, termed pathogen-associated molecular pat-
terns (PAMP), such as LPS and BLP (Medzhitov, 2001).
We observed potent adjuvanticity of apoptotic vesicles
from BCG-infected macrophages by activation through
TLR-2 and, in DCs, TLR-4. Immunoblotting of apoptotic
vesicle proteins revealed candidate molecules for the
adjuvant effect such as 19 kDa lipoprotein known to
stimulate through TLR-2 (Ciaramella et al., 2004; Lopez
et al., 2003). Because apoptosis permanently takes
place in the macroorganism to ensure homeostasis of
tissues and organs (Hengartner, 2000), cell death is
physiologically not associated with signals that entail
immune responses. Thus, the silencing function of apo-
ptosis is essential to preclude inflammation and autoim-
mune disease. For example, necrotic instead of apopto-
tic tumor cells induce crosspriming of CD8 T cells
(Sauter et al., 2000). However, in infectious disease,
apoptotic vesicles are equipped with a multitude of
PAMPs. Thus, pathogen-derived adjuvant molecules
override the silencing mechanisms of apoptosis by acti-
vation of APCs through TLRs, subsequently leading to
protective immune responses.
Tuberculosis is still a major global health threat, claim-
ing 2 million deaths per year (Kaufmann and McMichael,
2005). Although efficient antibiotics are available, the
complex regimen requires high compliance of patients
over several months and, thus, treatment is frequently
unsuccessful. Moreover, increased incidences of multi-
drug-resistant strains complicate therapy. Therefore,
development of a novel efficacious vaccine is crucial to
control tuberculosis, taking into account that the stan-
dard vaccination with the attenuated strainM.bovisBCG
only prevents severe forms of childhood disease (Kauf-
mann, 2001). Our results demonstrate that vaccination
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rophages induces protection against M. tuberculosis
compared to treatment with naive vesicles. In a com-
binatory approach linking vaccination and comparative
proteome analysis, novel antigen candidates can be de-
duced from the mycobacterial proteome of apoptotic
vesicles for future vaccination strategies.
Taken together, apoptotic vesicles represent an au-
tonomous immunological entity since they carry the
triad of antigen, antigen-presenting molecule, and adju-
vant for effective T cell activation. We propose the de-
tour pathway to reflect a genuine immunological mech-
anism for crosspriming of T cells in vivo and protection
against tuberculosis.
Experimental Procedures
Experimental Animals and Bacteria
6- to 8-week-old C57BL/6, OT-1, OT-2, b2m-, TLR-2-, TLR-4-, and
MyD88-KO mice were bred under specific pathogen-free conditions
in our facility at the Federal Institute for Health Protection of Con-
sumers and Veterinary Medicine (Berlin, Germany). OT-1 and OT-2
breeder mice were obtained from The Jackson Laboratories (Bar
Harbor, ME). OT-1 mice express a transgenic TCR, which recognizes
OVA residues 257–264 in the context of H-2Kb (Hogquist et al., 1994).
TCR-transgenic OT-2 mice are specific for the I-Ab restricted pep-
tide 323–339 of OVA (Barnden et al., 1998). CCR7-knockout mice
(Forster et al., 1999) were a kind gift from Dr. M. Lipp (Max-Del-
brueck-Centre for Molecular Medicine, Berlin, Germany), and
pSAP-deficient animals were bred at the Kekule´ Institute (Bonn, Ger-
many). M. tuberculosis H37Rv, M. bovis BCG (Danish strain), and re-
combinant M. bovis BCG-OVA were grown in 7H9 medium comple-
mented with albumin, dextrose, and catalase (ADC, Difco,
Germany). BCG-OVA was recombinantly engineered with a partial
sequence of the OVA gene (codons 230–359) under the control of
the HSP60 promoter (Dudani et al., 2002).
Infection, Apoptotic Vesicle Preparation, and Labeling
BCG or BCG-OVA were used for infection of macrophages at mid-
log phase of bacterial growth (A600 = 0.7) at an moi of 10:1. Bacterial
lysates were generated by sonication for 10 min at full level at 4ºC
with a Branson sonifier (Danbury, CT) equipped with a Titanium son-
ication cup. Infection was performed for 4 hr in the presence of 5%
horse serum. Apoptotic vesicles were generated from either nonin-
fected or BCG-infected macrophages cultured for 4–6 days in the
absence of FCS. Deprivation of FCS induced apoptotic vesicles in
both groups of macrophages. We described lower apoptosis of
macrophages after infection with BCG as compared to M. tubercu-
losis (Schaible et al., 2003). Yet, by extending the culture period of
infected cells, BCG sufficiently induced apoptotic cell death. Purifi-
cation of vesicles was realized by consecutive centrifugations at
8003 g, 1,8003 g, 25,0003 g, and 100,0003 g for 1 hr. High-speed
pellets were free of mycobacteria as verified by culture. From 43 108
macrophages, we purified vesicles equal to either 2.5–2.8 mg from
noninfected or 4.1–5 mg from infected cultures. All antigen prepara-
tions were adjusted to equivalent protein content of either 50 mg/ml
for immunization or 5 mg/ml for in vitro experiments as indicated
(BCA assay, Pierce, USA). Apoptotic vesicles were coupled to Texas
red (Molecular Probes, Netherlands) by hydrazide labeling accord-
ing to the manufacturer’s protocol.
Fluorescence, Confocal, and Electron Microscopy
Macrophages (1 3 105 per well) were seeded on 8-well multicham-
ber slides (Nalge Nunc International, USA). Subsequently, cells
were infected, stained for Annexin V, fixed with 4% paraformalde-
hyde (PFA), and embedded in Mowiol for analysis by an DM-IRBE
fluorescence microscope (Leica, Germany). For confocal micros-
copy, lymph node sections were mounted on slides, stained with
anti-CD11c-Alexa-488 (N 418) and anti-F4/80 coupled to Cy5, em-
bedded in Mowiol, and examined by a laser scanning microscope
(Leica TCS-NT, Germany). For scanning electron microscopy, mac-
rophages or apoptotic vesicles were fixed with 2.5% glutaraldehydeand postfixed by repeated incubations with 1% osmium tetroxid/1%
tannic acid. After dehydration with a graded ethanol series, speci-
mens were critical-point dried and coated with 2 nm platinum before
analysis on a Leo 1550 scanning electron microscope.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and can be found with this article online at http://www.immunity.
com/cgi/content/full/24/1/105/DC1/.
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